Bristol Myers Squibb has agreed to buy neuroscience-drug developer Karuna Therapeutics for $14 billion.

Bristol Myers Squibb has agreed to buy neuroscience-drug developer Karuna Therapeutics for $14 billion. https://ift.tt/mHP4Axh